HOME > Technology > New Drug Discovery and Development Process

RIBOMIC, Inc. is a leading company in the world developing innovative aptamer therapeutics.

New Drug Discovery and Development Process

New drug discovery and development requires a large amount of money in the hundreds of millions of dollars and more than a decade of time before the drug is brought onto the market.
   RIBOMIC Inc. is developing aptamer drug by applying the RiboART system (Ribomic Aptamer Refined Therapeutics system) during the stages involving the ① basic and exploratory research and ② pre-clinical studies.
   By applying the RiboART system, we have shorten the period from determination of the target protein to pre-toxic studies.
   The normal required research time from the basic and exploratory stages to preclinical studies (including a year of GLP studies) is 5~8 years. We believe it is possible to shorten the period to 3~4 years.

Normal new drug development process
※Pre-clinical studies (3~5 years) include about one year of GLP studies